Risk-Based Approaches to Post-Marketing Surveillance: Optimizing Resource Allocation
1. Introduction Post-marketing surveillance (PMS) is a critical phase in the lifecycle of any pharmaceutical product or medical device. It involves the systematic monitoring and evaluation of a product’s safety and effectiveness after it has been released into the market. This white paper delves into the transformative potential of risk-based approaches to PMS, offering insights […]